Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,801 to #4,850.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Depledge DP, et al, Nat. Commun. (2019), cited as Ref 195 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  2. Boldogkoi Z, et al, Trends Microbiol. (2019), cited as Ref 196 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  3. Xu Y, et al, Front. Microbiol. (2018), cited as Ref 197 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  4. Erlwein O, et al, PLoS ONE (2011), cited as Ref 198 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  5. Karamitros T, et al, Nucleic Acids Res. (2015), cited as Ref 199 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  6. Vinaya Kumar K, et al, Genome Announc. (2018), cited as Ref 200 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  7. Gunther T, et al, Sci. Rep. (2017), cited as Ref 201 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  8. Warwick-Dugdale J, et al, PeerJ (2019), cited as Ref 202 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  9. Peserico A, et al, Sci. Rep. (2019), cited as Ref 203 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  10. Theuns S, et al, Sci. Rep. (2018), cited as Ref 204 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  11. Bronzato Badial A, et al, Plant Dis. (2018), cited as Ref 205 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  12. Gallagher MD, et al, Sci. Rep. (2018), cited as Ref 206 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  13. Ameur A, et al, Trends Biotechnol. (2019), cited as Ref 207 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  14. Houldcroft CJ, et al, Front. Microbiol. (2015), cited as Ref 208 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  15. Munro AC, et al, Future Virol. (2016), cited as Ref 209 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  16. Hue S, et al, R, etrovirology (2010), cited as Ref 210 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  17. Naccache SN, et al, J. Virol. (2013), cited as Ref 211 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  18. Salter SJ, et al, BMC Biol. (2014), cited as Ref 212 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  19. Matsvay AD, et al, Conserv. Gen, et. Resour. (2019), cited as Ref 213 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  20. Morfopoulou S, et al, N. Engl. J. Med. (2016), cited as Ref 214 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  21. Lipkin WI, et al, J. Infect. Dis. (2015), cited as Ref 215 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  22. Hall RJ, et al, Front. Microbiol. (2015), cited as Ref 216 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  23. Shafer RW, et al, J. Infect. Dis. (2006), cited as Ref 217 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  24. Gnaneshan S, et al, Nucleic Acids Res. (2007), cited as Ref 218 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  25. Rhee S-Y, et al, Antivir. Res. (2010), cited as Ref 219 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  26. Kuiken C, et al, Bioinformatics (2005), cited as Ref 220 in DOI: 10.3390/v12020211‏‎ (02:57, 24 May 2020)
  27. Section 3.2. Problems of Metagenomic Approach (from DOI: 10.3390/v12020211)‏‎ (18:34, 25 May 2020)
  28. Section 3.1. Metagenomic Approach (from DOI: 10.3390/v12020211)‏‎ (18:35, 25 May 2020)
  29. Section 3. Studying Viral Pathogens with High Throughput Sequencing (HTS) (from DOI: 10.3390/v12020211)‏‎ (18:35, 25 May 2020)
  30. Section 2. Traditional Methods of Diagnosing Infections (from DOI: 10.3390/v12020211)‏‎ (18:35, 25 May 2020)
  31. Section 1. Introduction (from DOI: 10.3390/v12020211)‏‎ (18:36, 25 May 2020)
  32. Section 3.3.1. Nucleic Acids Depletion (from DOI: 10.3390/v12020211)‏‎ (18:36, 25 May 2020)
  33. Section 3.3.2. Hybridization-Based Enrichment (from DOI: 10.3390/v12020211)‏‎ (18:37, 25 May 2020)
  34. Section 3.3.3. Target Amplification (from DOI: 10.3390/v12020211)‏‎ (18:37, 25 May 2020)
  35. Section 3.4. Whole Viral Genome Sequencing (from DOI: 10.3390/v12020211)‏‎ (18:37, 25 May 2020)
  36. Section 3.5. Methods of Sequencing Data Analysis (from DOI: 10.3390/v12020211)‏‎ (18:38, 25 May 2020)
  37. Section 3.3. Methods for Improving Sequencing Output (from DOI: 10.3390/v12020211)‏‎ (18:39, 25 May 2020)
  38. Section 4. Long Read Sequencing (from DOI: 10.3390/v12020211)‏‎ (18:40, 25 May 2020)
  39. Section 5. Obstacles to Overcome in the Nearest Future (from DOI: 10.3390/v12020211)‏‎ (18:40, 25 May 2020)
  40. Section 6. Conclusions (from DOI: 10.3390/v12020211)‏‎ (18:42, 25 May 2020)
  41. Author Contributions (from DOI: 10.3390/v12020211)‏‎ (18:42, 25 May 2020)
  42. Funding (from DOI: 10.3390/v12020211)‏‎ (18:43, 25 May 2020)
  43. Conflicts of Interest (from DOI: 10.3390/v12020211)‏‎ (18:43, 25 May 2020)
  44. References (from DOI: 10.3390/v12020211)‏‎ (21:29, 25 May 2020)
  45. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection (DOI: 10.1183/13993003.01023-2020)‏‎ (14:52, 12 June 2020)
  46. Cucinotta D, et al, Acta Biomed. (2020), cited as Ref 1 in DOI: 10.1016/j.jcv.2020.104372‏‎ (14:37, 18 June 2020)
  47. John's Hopkins University, et al, (2020), cited as Ref 2 in DOI: 10.1016/j.jcv.2020.104372‏‎ (14:37, 18 June 2020)
  48. Mullins E, et al, Ultrasound Obstet. Gynecol. (2020), cited as Ref 3 in DOI: 10.1016/j.jcv.2020.104372‏‎ (14:37, 18 June 2020)
  49. Karimi-Zarchi M, et al, Fetal Pediatr. Pathol. (2020), cited as Ref 4 in DOI: 10.1016/j.jcv.2020.104372‏‎ (14:37, 18 June 2020)
  50. Nahmias AJ, et al, Pediatr. Res. (1971), cited as Ref 5 in DOI: 10.1016/j.jcv.2020.104372‏‎ (14:37, 18 June 2020)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)